Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 176,560 | 158,228 | 102,775 | 52,561 | 37,696 |
| Operating Income | -176,560 | -158,228 | -102,775 | -52,561 | -37,696 |
| Other Income | 35,873 | 36,012 | 13,391 | 1,257 | -122 |
| Pre-tax Income | -140,687 | -122,216 | -89,384 | -51,304 | -37,818 |
| Income Tax | 515 | 310 | 236 | 17 | 231 |
| Net Income Continuous | -141,202 | -122,526 | -89,620 | -51,321 | -38,049 |
| Net Income | $-141,202 | $-122,526 | $-89,620 | $-51,321 | $-38,049 |
| EPS Basic Total Ops | -2.39 | -2.33 | -2.44 | -16.54 | -16.13 |
| EPS Basic Continuous Ops | -2.39 | -2.33 | -2.44 | -16.06 | -14.02 |
| EPS Diluted Total Ops | -2.39 | -2.33 | -2.44 | -16.54 | -16.13 |
| EPS Diluted Continuous Ops | -2.39 | -2.33 | -2.44 | -16.06 | -14.02 |
| EPS Diluted Before Non-Recurring Items | -1.42 | -0.78 | -0.81 | -5.51 | N/A |
| EBITDA(a) | $-174,882 | $-157,232 | $-102,459 | $-53,189 | $-37,550 |